Published in Obesity and Diabetes Week, July 7th, 2003
If larger studies confirm these results, the drug, called rosiglitazone (Avandia; GlaxoSmithKline), may be a good choice for patients with type 2 diabetes who require additional medications to prevent heart attacks.
"If you have a diabetes drug that lowers not only blood sugar but also the risk for heart disease, that might be favorable for the patient with diabetes who already takes as many as 8 to 12 pills a day," said James W. Chu, MD, director of the Diabetes Center at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.